GEO Publications
Handout
NAR 2024 (latest)
NAR 2002 (original)
All publications
FAQ
MIAME
Email GEO
NCBI
>
GEO
>
Accession Display
Not logged in |
Login
GEO help:
Mouse over screen elements for information.
Scope:
Self
Platform
Samples
Series
Family
Format:
HTML
SOFT
MINiML
Amount:
Brief
Quick
GEO accession:
Sample GSM31096
Query DataSets for GSM31096
Status
Public on Oct 28, 2004
Title
CBCD34_setC_2hr
Sample type
RNA
Source name
umbilical cord blood CD34+ cells, 2 hrs TGF-beta treatment
Organism
Homo sapiens
Extracted molecule
total RNA
Description
Total RNA
RNeasy extraction
Two rounds amplification (RT+IVT) Ambion MessageAmp kit
Submission date
Sep 28, 2004
Last update date
May 27, 2005
Contact name
Agnes Viale
E-mail(s)
vialea@mskcc.org
Phone
212 639 3031
Fax
212 717 3053
Organization name
Memorial Sloan Kettering Cancer Center
Department
Molecular Biology
Lab
Genomics Core Laboratory
Street address
1275 York Avenue
City
New York
State/province
NY
ZIP/Postal code
10021
Country
USA
Platform ID
GPL96
Series (1)
GSE1802
CBCD34-TGFbeta targets
Data table header descriptions
ID_REF
VALUE
signal intensity
ABS_CALL
absolute detection call where P=present, A=absent, and M=marginal
DETECTION P-VALUE
confidence on call
Data table
ID_REF
VALUE
ABS_CALL
DETECTION P-VALUE
AFFX-BioB-5_at
889.9
P
0.000169
AFFX-BioB-M_at
1878.5
P
0.000044
AFFX-BioB-3_at
1203.2
P
0.000052
AFFX-BioC-5_at
2308.8
P
0.000052
AFFX-BioC-3_at
1987
P
0.000044
AFFX-BioDn-5_at
3272.3
P
0.000044
AFFX-BioDn-3_at
11181.6
P
0.000044
AFFX-CreX-5_at
17964.5
P
0.000044
AFFX-CreX-3_at
26347.6
P
0.000044
AFFX-DapX-5_at
17
A
0.131361
AFFX-DapX-M_at
6.6
A
0.760937
AFFX-DapX-3_at
1.3
A
0.996405
AFFX-LysX-5_at
1.7
A
0.904333
AFFX-LysX-M_at
5.7
A
0.737173
AFFX-LysX-3_at
9.1
A
0.544587
AFFX-PheX-5_at
1.5
A
0.989683
AFFX-PheX-M_at
3.1
A
0.724854
AFFX-PheX-3_at
52.1
A
0.139482
AFFX-ThrX-5_at
3.2
A
0.860518
AFFX-ThrX-M_at
3.2
A
0.860518
Total number of rows:
22283
Table truncated, full table size
589 Kbytes
.
Supplementary data files not provided
|
NLM
|
NIH
|
GEO Help
|
Disclaimer
|
Accessibility
|